The Lancet Gastroenterology & Hepatology in conversation with Podcast Por The Lancet Group arte de portada

The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Gastroenterology & Hepatology in conversation with

De: The Lancet Group
Escúchala gratis

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

© 2025 The Lancet Group
Ciencia Ciencias Biológicas Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection
    Nov 28 2025

    Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies.

    Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    16 m
  • Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS
    Nov 20 2025

    Do wheat or gluten trigger IBS symptoms?

    We spoke to Premysl Bercik about a randomised, double-blind, sham-controlled crossover trial that challenged adults with IBS—who reported benefit from a gluten-free diet—with wheat, gluten, or a gluten-free sham to test symptom and behavioural responses.

    Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00090-1/fulltext

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    16 m
  • Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma
    Jun 19 2025

    Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk patients.

    Read the full article:

    https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00056-1/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langas

    Continue this conversation on social!

    Follow us today at...

    https://bsky.app/profile/lancetgastrohep.bsky.social

    https://www.linkedin.com/company/langastro/

    https://instagram.com/thelancetgroup

    https://facebook.com/thelancetmedicaljournal

    https://youtube.com/thelancettv

    Más Menos
    27 m
Todavía no hay opiniones